Cargando…
Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA)
SIMPLE SUMMARY: Prostate cancer (PCa) is the second most common cancer and one of the highestcauses of cancer deaths among men. The presence of lymph node metastases (LNM) is the strongest prognostic factor. Histological detection of LNM is the gold standard for LN staging. In clinical practice, onl...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961354/ https://www.ncbi.nlm.nih.gov/pubmed/33807774 http://dx.doi.org/10.3390/cancers13051117 |
_version_ | 1783665241192660992 |
---|---|
author | Engels, Svenja Brautmeier, Lutz Reinhardt, Lena Wasylow, Clara Hasselmann, Friederike Henke, Rolf P. Wawroschek, Friedhelm Winter, Alexander |
author_facet | Engels, Svenja Brautmeier, Lutz Reinhardt, Lena Wasylow, Clara Hasselmann, Friederike Henke, Rolf P. Wawroschek, Friedhelm Winter, Alexander |
author_sort | Engels, Svenja |
collection | PubMed |
description | SIMPLE SUMMARY: Prostate cancer (PCa) is the second most common cancer and one of the highestcauses of cancer deaths among men. The presence of lymph node metastases (LNM) is the strongest prognostic factor. Histological detection of LNM is the gold standard for LN staging. In clinical practice, only fractions of LNs are examined histopathologically, resulting in missed (micro-)metastases. Biomolecular techniques can enhance the identification of LNM but are not routinely used because of high cost. One-step nucleic acid amplification (OSNA) analyzes the entire LN by detecting cytokeratin 19 mRNA as a surrogate for LNM requiring less effort and allowing intraoperative application. To verify the reliability of OSNA for the first time in PCa, we examined LNs of patients undergoing prostatectomy and sentinel lymphadenectomy. Results were compared with histopathological and immunohistochemistry findings. OSNA identified LNM equivalent to, or in cases of micrometastases, even better than enhanced histopathology, and might be useful in intraoperative decision-making in personalized LN surgery. ABSTRACT: Background: In clinical routine, only fractions of lymph nodes (LNs) are examined histopathologically, often resulting in missed (micro-)metastases and incorrect staging of prostate cancer (PCa). One-step nucleic acid amplification (OSNA) analyzes the entire LN by detecting cytokeratin 19 (CK19) mRNA as a surrogate for LN metastases requiring less effort than conventional biomolecular techniques. We aimed to evaluate performance of OSNA in detecting sentinel LN (SLN) metastases in PCa. Methods: SLNs (n = 534) of 64 intermediate- or high-risk PCa patients undergoing radical prostatectomy with extended and sentinel-guided lymphadenectomy were cut into slices and alternatingly assigned to OSNA and histopathology (hematoxylin-eosin staining, CK19, and CK AE1/AE3 immunohistochemistry). Sensitivity and specificity of OSNA and concordance and measure of agreement (Cohen’s kappa (κ)) between OSNA and histopathology were assessed. Results: Histopathology revealed metastases in 76 SLNs. Sensitivity and specificity of OSNA were 84.2% and 96.1%, respectively. Discordant results were recorded for 30 of 534 SLNs, revealing high concordance (94.4%). Twenty-four discordant cases were classified as micrometastases, indicating a possible allocation bias. In 18 cases, positive results were conferred only by OSNA resulting in seven LN-positive patients who were missed by histopathology. Overall, the level of agreement was high (κ = 0.78). Conclusions: OSNA provided a diagnosis that was as least as accurate as detailed histological examination and might improve LN staging in PCa. |
format | Online Article Text |
id | pubmed-7961354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79613542021-03-17 Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) Engels, Svenja Brautmeier, Lutz Reinhardt, Lena Wasylow, Clara Hasselmann, Friederike Henke, Rolf P. Wawroschek, Friedhelm Winter, Alexander Cancers (Basel) Article SIMPLE SUMMARY: Prostate cancer (PCa) is the second most common cancer and one of the highestcauses of cancer deaths among men. The presence of lymph node metastases (LNM) is the strongest prognostic factor. Histological detection of LNM is the gold standard for LN staging. In clinical practice, only fractions of LNs are examined histopathologically, resulting in missed (micro-)metastases. Biomolecular techniques can enhance the identification of LNM but are not routinely used because of high cost. One-step nucleic acid amplification (OSNA) analyzes the entire LN by detecting cytokeratin 19 mRNA as a surrogate for LNM requiring less effort and allowing intraoperative application. To verify the reliability of OSNA for the first time in PCa, we examined LNs of patients undergoing prostatectomy and sentinel lymphadenectomy. Results were compared with histopathological and immunohistochemistry findings. OSNA identified LNM equivalent to, or in cases of micrometastases, even better than enhanced histopathology, and might be useful in intraoperative decision-making in personalized LN surgery. ABSTRACT: Background: In clinical routine, only fractions of lymph nodes (LNs) are examined histopathologically, often resulting in missed (micro-)metastases and incorrect staging of prostate cancer (PCa). One-step nucleic acid amplification (OSNA) analyzes the entire LN by detecting cytokeratin 19 (CK19) mRNA as a surrogate for LN metastases requiring less effort than conventional biomolecular techniques. We aimed to evaluate performance of OSNA in detecting sentinel LN (SLN) metastases in PCa. Methods: SLNs (n = 534) of 64 intermediate- or high-risk PCa patients undergoing radical prostatectomy with extended and sentinel-guided lymphadenectomy were cut into slices and alternatingly assigned to OSNA and histopathology (hematoxylin-eosin staining, CK19, and CK AE1/AE3 immunohistochemistry). Sensitivity and specificity of OSNA and concordance and measure of agreement (Cohen’s kappa (κ)) between OSNA and histopathology were assessed. Results: Histopathology revealed metastases in 76 SLNs. Sensitivity and specificity of OSNA were 84.2% and 96.1%, respectively. Discordant results were recorded for 30 of 534 SLNs, revealing high concordance (94.4%). Twenty-four discordant cases were classified as micrometastases, indicating a possible allocation bias. In 18 cases, positive results were conferred only by OSNA resulting in seven LN-positive patients who were missed by histopathology. Overall, the level of agreement was high (κ = 0.78). Conclusions: OSNA provided a diagnosis that was as least as accurate as detailed histological examination and might improve LN staging in PCa. MDPI 2021-03-05 /pmc/articles/PMC7961354/ /pubmed/33807774 http://dx.doi.org/10.3390/cancers13051117 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Engels, Svenja Brautmeier, Lutz Reinhardt, Lena Wasylow, Clara Hasselmann, Friederike Henke, Rolf P. Wawroschek, Friedhelm Winter, Alexander Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) |
title | Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) |
title_full | Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) |
title_fullStr | Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) |
title_full_unstemmed | Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) |
title_short | Evaluation of Fast Molecular Detection of Lymph Node Metastases in Prostate Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) |
title_sort | evaluation of fast molecular detection of lymph node metastases in prostate cancer patients using one-step nucleic acid amplification (osna) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961354/ https://www.ncbi.nlm.nih.gov/pubmed/33807774 http://dx.doi.org/10.3390/cancers13051117 |
work_keys_str_mv | AT engelssvenja evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna AT brautmeierlutz evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna AT reinhardtlena evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna AT wasylowclara evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna AT hasselmannfriederike evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna AT henkerolfp evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna AT wawroschekfriedhelm evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna AT winteralexander evaluationoffastmoleculardetectionoflymphnodemetastasesinprostatecancerpatientsusingonestepnucleicacidamplificationosna |